|
Atomistry » Chlorine » PDB 2vg2-2vo5 » 2viw | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 2vg2-2vo5 » 2viw » |
Chlorine in PDB 2viw: Fragment-Based Discovery of Mexiletine Derivatives As Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen ActivatorEnzymatic activity of Fragment-Based Discovery of Mexiletine Derivatives As Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator
All present enzymatic activity of Fragment-Based Discovery of Mexiletine Derivatives As Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator:
3.4.21.73; Protein crystallography data
The structure of Fragment-Based Discovery of Mexiletine Derivatives As Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator, PDB code: 2viw
was solved by
M.Frederickson,
O.Callaghan,
G.Chessari,
M.Congreve,
S.R.Cowan,
J.E.Matthews,
R.Mcmenamin,
D.Smith,
M.Vinkovic,
N.G.Wallis,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Fragment-Based Discovery of Mexiletine Derivatives As Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator
(pdb code 2viw). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Fragment-Based Discovery of Mexiletine Derivatives As Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator, PDB code: 2viw: Chlorine binding site 1 out of 1 in 2viwGo back to![]() ![]()
Chlorine binding site 1 out
of 1 in the Fragment-Based Discovery of Mexiletine Derivatives As Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator
![]() Mono view ![]() Stereo pair view
Reference:
M.Frederickson,
O.Callaghan,
G.Chessari,
M.Congreve,
S.R.Cowan,
J.E.Matthews,
R.Mcmenamin,
D.Smith,
M.Vinkovic,
N.G.Wallis.
Fragment-Based Discovery of Mexiletine Derivatives As Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator. J.Med.Chem. V. 51 183 2008.
Page generated: Fri Jul 11 00:50:25 2025
ISSN: ISSN 0022-2623 PubMed: 18163548 DOI: 10.1021/JM701359Z |
Last articlesNa in 8BEONa in 8BFE Na in 8BGX Na in 8BGZ Na in 8BGY Na in 8BGJ Na in 8BDC Na in 8BFD Na in 8BB0 Na in 8BBS |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |